Pacer Advisors, Inc. Alkermes Plc. Transaction History
Pacer Advisors, Inc.
- $40.5 Billion
- Q4 2024
A detailed history of Pacer Advisors, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 3,463,082 shares of ALKS stock, worth $116 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
3,463,082
Previous 4,165,390
16.86%
Holding current value
$116 Million
Previous $117 Million
14.57%
% of portfolio
0.25%
Previous 0.28%
Shares
8 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$976 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$620 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$411 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$296 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$253 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.51B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...